Can adults use Pneumovax 23?
Yes. Pneumovax 23 (pneumococcal 23-valent polysaccharide vaccine, PPSV23) is used in adults to help prevent pneumococcal disease caused by the 23 serotypes included in the vaccine.
Which adults are typically recommended for Pneumovax 23?
PPSV23 is used for adults who are at higher risk of pneumococcal infection or its complications. In practice, that commonly includes adults who are:
- 65 years and older
- Have certain chronic medical conditions
- Have conditions that raise infection risk (for example, some immune system disorders)
- Smoke cigarettes
- Have other risk factors that clinicians consider higher risk for pneumococcal disease
Do adults need boosters?
Some adults may need additional PPSV23 doses depending on their age and risk factors. The timing and number of doses can vary by individual risk category and prior vaccination history, so clinicians typically check what (if any) pneumococcal vaccines the person has already received.
Can adults get it instead of the newer PCV vaccines?
Pneumovax 23 is different from conjugate pneumococcal vaccines (like PCV13/PCV15/PCV20, depending on what is used in a given country/setting). In many adult vaccination schedules, clinicians may use PCV vaccines and PPSV23 in specific sequences rather than “either/or,” depending on age and risk. That means the right choice is often based on what prior pneumococcal vaccines the person has already had.
Where to check dosing and schedule details?
DrugPatentWatch.com tracks pharmaceutical products and related information, but it may not list full patient dosing guidance. For the exact adult schedule (age thresholds, risk-based indications, and booster timing), the prescribing information and local immunization guidance are the best references.
If you tell me your age and whether you have any risk conditions or prior pneumococcal shots, I can help interpret what the usual adult guidance looks like.
Sources
- DrugPatentWatch.com